Super Powers in race to get their Covid-19 Vaccines adopted by governments worldwide | Algeria is first African country to register Russia’s Sputnik V

Western and eastern super powers are in manic race to get their own Covid-19 vaccine deployed around the world. The vaccine is seen as an extension of their respective empire’s geopolitical outreach and influence.

While the  UK and US have their Pfizer, Moderna, and Oxford-AstraZeneca vaccines approved by their governments, Russia has had its Sputnik V.

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People’s Democratic Republic of Algeria – Africa’s first

Russian Direct Investment Fund Logo

The vaccine was registered under the emergency use authorization procedure. Sputnik V has been registered under the same procedure earlier in ArgentinaBolivia and Serbia.

Supplies of the vaccine to Algeria will be facilitated by international partners of RDIF in IndiaChinaSouth Korea and other countries.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said: “RDIF welcomes the first registration of Sputnik V vaccine in Africa. The supplies of the vaccine to Algeria will help protect the population and support the full recovery of economic activity”.
Sputnik V info as presented by the Russian authorities:
  • Efficacy of Sputnik V is over 90%, with full protection against severe cases of COVID-19.
  • The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
  • Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
  • The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
  • Over 1.5mn people have already been vaccinated with Sputnik V.
  • The developers of the Sputnik V vaccine are working collaboratively with AstraZeneca on a joint clinical trial to improve the efficacy of AstraZeneca vaccine.
  • The Sputnik V vaccine has been approved in RussiaBelarus, Serbia, ArgentinaBolivia, the process to approve the vaccine in the EU has been initiated.
  • There are no strong allergies caused by Sputnik V.
  • The storage temperature of Sputnik V at +2+8 C means it can be stored in a conventional refrigerator without any need to invest in additional cold-chain infrastructure.
  • The price of Sputnik V is less than $10 per shot, making it affordable around the world.

 


Are you Citizen-Journalist Material?

Have a tip or scoop? Do you have info about corruption that needs to be investigated and responsibly exposed ? Get in touch securely via WhatsApp at +44 7771 927378 | Signal at +447766 098270


Receive Exclusives, Features & News Updates

Subscribe